Rising Antimicrobial Resistance in Urinary Tract Infections in Bangladesh: A Microbiological Analysis
Abstract
Background: Antimicrobial resistance (AMR) in urinary tract infections (UTIs) is a growing global health issue, complicating treatment strategies and increasing healthcare burdens.Aim: This study aims to analyze the microbiological profile of UTIs and evaluate resistance patterns of uropathogens across different antimicrobial agents.Materials and Methods: This retrospective, observational study was carried out in Mount Adora Hospital, Akhalia, Sylhet.Data record were reviewed from July 1 st , 2023 to February 29 th 2024 and all the urine culture-positive reports were collected with the organism isolated and their antibiotic resistance to different organisms.Results: This study included 783 UTI patients, with a male-to-female ratio of 1:2.16 and a mean age of 52.82 years.Escherichia coli was the most common uropathogen (54.5%), followed by Klebsiella sp.(20.4%) and Pseudomonas sp.(11.6%).High resistance was observed against Azithromycin (80.9%),Nalidixic Acid (79.1%) and Cefixime (78.3).Among injectables, Tigecycline (4.3%), Imipenem (13.4%), and Colistin (15.1%) showed the lowest resistance.Conclusion: The study demonstrates significant rise in antimicrobial resistance in UTIs in Bangladesh, particularly against commonly used antibiotics.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.